Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
99750-2 Satisfaction level with LASIK result Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Satisfaction level with LASIK result &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99750-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99751-0 Satisfaction level with length of time for vision improvement after LASIK Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Satisfaction level with length of time for vision improvement after LASIK &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99751-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Len; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99752-8 Satisfaction level with length of time it took for improvement in post-operative discomfort after LASIK Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Satisfaction level with length of time it took for improvement in post-operative discomfort after LASIK &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99752-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; After; Finding; Findings; Len; Levels; Levl; LV; LVL; Ordinal; Point in time; PST; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99753-6 Level of understanding risk and benefit of LASIK before treatment Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Level of understanding risk and benefit of LASIK before treatment &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99753-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Tx 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99754-4 When not wearing corrective lenses, distance vision is as good as anticipated after LASIK Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE When not wearing corrective lenses, distance vision is as good as anticipated after LASIK &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99754-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99755-1 Wear corrective lenses to see in the distance Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Wear corrective lenses to see in the distance &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99755-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99756-9 Goal for LASIK achieved Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Goal for LASIK achieved &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99756-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99757-7 Happiness level of having LASIK Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Happiness level of having LASIK &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99757-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99759-3 Would recommend LASIK to friend or family member Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Would recommend LASIK to friend or family member &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99759-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9976-2 QRS terminal amplitude.lead I Elpot Heart Pt Qn EKG &nbsp; ACTIVE QRS terminal amplitude in lead I &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9976-2 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 QRS T-Amp L-I &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS T-Amp L-I; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
99760-1 Reason not to have or recommend LASIK Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Reason not to have or recommend LASIK &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.PROWL &nbsp; 99760-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99761-9 Clot initiation.kaolin induced Time Bld Pt Qn Thromboelastography.resonance &nbsp; ACTIVE Clot initiation.kaolin induced [Time] in Blood by Resonance TEG &nbsp; MIN DefinitionDescription &nbsp; &nbsp; min &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 99761-9 &nbsp; Thromboelastography.resonance &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clot init kao ind p hep neut Bld Res TEG &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Clot init kao ind p hep neut; Clot init kaolin ind; COAGULATION; CT; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.75 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; min &nbsp; &nbsp; &nbsp; 0
99762-7 Clot angle.kaolin induced Angle Bld Pt Qn Thromboelastography.resonance &nbsp; ACTIVE Clot angle.kaolin induced in Blood by Resonance TEG &nbsp; ADD DefinitionDescription &nbsp; &nbsp; degrees &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 99762-7 &nbsp; Thromboelastography.resonance &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clot angle.kaolin induced Bld Res TEG &nbsp; &nbsp; &nbsp; N &nbsp; Blood; COAGULATION; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; deg &nbsp; &nbsp; &nbsp; 0
99763-5 Clot formation.kaolin induced Time Bld Pt Qn Thromboelastography.resonance &nbsp; ACTIVE Clot formation.kaolin induced [Time] in Blood by Resonance TEG &nbsp; ADD DefinitionDescription &nbsp; &nbsp; min &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 99763-5 &nbsp; Thromboelastography.resonance &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CFT form kaolin ind Bld Res TEG &nbsp; &nbsp; &nbsp; N &nbsp; Activated clotting time; Blood; CFT; CFT form kaolin ind; Clot time; COAGULATION; Kinetics; k-time; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; min &nbsp; &nbsp; &nbsp; 0
99764-3 Interferon.gamma MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Interferon gamma [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 99764-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 IGNF CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; G-INF; HEMATOLOGY/CELL COUNTS; IFN; IGNF; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
99765-0 Interleukin 12 MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Interleukin 12 [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99765-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Il12 CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Edodekin Alfa; IL; IL12; IL-12; Level; Mass concentration; Natural Killer Cell Stimulatory Factor; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
99766-8 Interleukin 17 MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Interleukin 17 [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99766-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 IL-17 CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IL; IL-17; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
99767-6 Interleukin 1 beta MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Interleukin 1 beta [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99767-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Il1Beta CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; B; Cerebral spinal fluid; Cerebrospinal Fl; CG Antigen-Specific Helper Factor; Chemistry; Epidermal Cell Derived Thymocyte-Activating Factor; ETAF; i; IL; IL1; IL-1; IL-1B; Il1Beta; IL-1�²; Level; Lymphocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T Helper Factor 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
99768-4 Interleukin 2 receptor.soluble MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Interleukin 2 Receptor Soluble [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99768-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Sol Il2 Recep CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Costimulator; II; IL; IL2; IL-2; IL2R; IL-2R; Il2Recep; ILR2; Level; Lymphocyte Mitogenic Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; sIL-2R; Sol Il2 Recep; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T-Cell Growth Factor; T-Cell Stimulating Factor; TCGF; Thymocyte Stimulating Factor 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
99769-2 Interleukin 8 MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Interleukin 8 [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99769-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Il8 CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Anionic Neutrophil-Activating Peptide; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Chemotactic Factor, Macrophage-Derived; Chemotactic Factor, Neutrophil; Chemotactic Factor, Neutrophil, Monocyte-Derived; IL; Il8; IL-8; Leukocyte Adhesion Inhibitor; Level; Mass concentration; Neutrophil Activation Factor; Neutrophil-Activating Peptide, Lymphocyte-Derived; Neutrophil-Activating Peptide, Monocyte-Derived; Neutrophil-Activating Peptides, Fibroblast-Derived; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
9977-0 QRS terminal amplitude.lead II Elpot Heart Pt Qn EKG &nbsp; ACTIVE QRS terminal amplitude in lead II &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9977-0 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 QRS T-Amp L-II &nbsp; &nbsp; &nbsp; Y &nbsp; 2; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS T-Amp L-II; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
99770-0 Tumor necrosis factor.alpha MCnc CSF Pt Qn &nbsp; &nbsp; ACTIVE Tumor necrosis factor.alpha [Mass/volume] in Cerebral spinal fluid &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pg/ml &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99770-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 A-Tumor Necrosis Fact CSF-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Alfa; A-Tumor Necrosis Fact; Cachectin; Cachectine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Fac; Fact; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; TNF 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
99771-8 SARS coronavirus 2 spike & nucleocapsid protein stimulated gamma interferon panel - Bld Pt - &nbsp; &nbsp; ACTIVE SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.MICRO &nbsp; 99771-8 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 SARS-CoV-2 IGRA Spk+Nuclcp Pnl Bld &nbsp; &nbsp; &nbsp; N &nbsp; 2019 Novel Coronavirus; 2019-nCoV; Blood; Corona virus; COVID19; COVID-19; ID; IFN; IGRA; II; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; PR; Prot; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IGRA Spk+Nuclcp Pnl; Severe Acute Respiratory Syndrome; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99772-6 SARS coronavirus 2 stimulated gamma interferon Imp Bld Pt Ord &nbsp; &nbsp; ACTIVE SARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 99772-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 SARS-CoV-2 IFN-g Bld-Imp &nbsp; &nbsp; &nbsp; N &nbsp; 2019 Novel Coronavirus; 2019-nCoV; Blood; Corona virus; COVID19; COVID-19; ID; IFN; IGRA; II; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; Screen; Severe Acute Respiratory Syndrome; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99773-4 SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count^^corrected for background Num Bld Pt Qn &nbsp; &nbsp; ACTIVE SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood &nbsp; ADD DefinitionDescription &nbsp; &nbsp; # &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 99773-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 SARSCoV2 IGRA Spike Ct bckgrd cor Bld &nbsp; &nbsp; &nbsp; N &nbsp; 2019 Novel Coronavirus; 2019-nCoV; bckgrd cor; Blood; Cell; Cellularity; Cnt; Corona virus; Count; COVID19; COVID-19; ID; IFN; IGRA; II; Infectious Disease; InfectiousDisease; Microbiology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g T cells; SARSCoV2 IGRA Spike Ct; Severe Acute Respiratory Syndrome; T prime; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {#} &nbsp; &nbsp; &nbsp; 0
108,248 results found